Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Mitinab 400mg Tablet
Manufacturer/Marketed By : GLENMARK PHARMACEUTICALS LTD
$22.71 $10.67
Mitinab 400mg tablets contains the active substance imatinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. This tablet is used treating adults and children with...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
IMATINIB
Active Pharmaceutical Ingredient
Mitinab 400mg Tablet
22,71$
10,67$
Mitinab 400mg tablets contains the active substance imatinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. This tablet is used treating adults and children with chronic myeloid leukemia (CML- it is a form of leukemia in which certain abnormal white blood cells start growing out of control). It is also indicated to treat philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL). It is also used to treat certain types of gastrointestinal stromal tumors (GIST; a type of tumor that grows in the walls of the digestive passages and may spread to other parts of the body) Mitinab 400mg tablet is also used to treat myelodysplastic/myeloproliferative diseases (MDS/MPD), these are a group of blood diseases in which some blood cells start growing out of control. They also treats hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL), these are blood diseases in which some blood cells (eosinophils) start growing out of control. This medicine is also intented to treat dermatofibrosarcoma protuberans (DFSP), a cancer of the tissue beneath the skin in which some cells start growing abnormally. It works inhibiting the growth of these abnormal blood cells. Do not take Mitinab 400mg tablet if you are allergic to imatinib or any other ingredients of this medicine. Before initiating the treatment, inform your physician if you have kidney, heart or liver problems, if you have thyroid problems or your thyroid gland has been removed. Notify your doctor if you ever had or have a hepatitis B infection because this medicine could cause the hepatitis B to become active again. Report any symptoms of bruising, bleeding, fever, fatigue and confusion when taking this medicine. This medicine may cause fertility problems.
Active Pharmaceutical Ingredient
Uses
• Chronic myeloid leukemia (CML)
• Philadelphia chromosome positive acute lymphoblastic leukemia (ph-positive ALL)
• Myelodysplastic/myeloproliferative diseases (MDS/MPD)
• Hypereosinophilic syndrome (HES)
• Chronic eosinophilic leukemia (CEL)
• Dermatofibrosarcoma protuberans (DFSP)
• Gastrointestinal stromal tumors (GIST)
Benefits
Mitinab 400mg tablet is a protein-tyrosine kinase inhibitor that blocks a specific abnormal protein created by chromosomal abnormality that signals cancer cells to multiply. It inhibits the multiplication and induces cell death in abnormal cancer cells.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Heart failure
• GI disorders
• Hypothyroidism
• Liver failure
• Swelling in the body
Common Side Effects
• Swelling in the face, legs, ankle and feet
• Nausea, vomiting
• Muscle cramps and pain
• Diarrhea
• Skin rash, night sweats
• Tiredness, dizziness
• Abdominal pain
• Increased weight
• Decreased RBC and WBC cells
• Headache
• Cough, Inflammation in the nose
• Fever, lack of sleep
How To Use
Your doctor will decide the dose and duration of the treatment based on your disease condition, severity and other factors. Take the tablets as prescribed by your doctor. Do not break, crush, or chew the tablets. Swallow the tablet whole with a glass of water. Take this medicine with a meal to avoid stomach problems. If you are unable to swallow the tablets, you can dissolve them as per your doctor advice.
Safety Advice
• Breast Feeding: Breastfeeding is not recommended in patients taking Mitinab 400mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby.
• Alcohol: It is unknown whether it is safe to consume alcohol when taking Mitinab 400mg tablet. Consult your doctor for more advice.
• Liver: It is unknown whether Mitinab 400mg tablet can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Lungs: Mitinab 400mg tablet is unsafe when administered in patients with severe liver diseases. Dose adjustments are necessary in severe liver failure. Inform your physician if you have liver problems before initiating the therapy.
• Driving: It is unsafe to drive or operate heavy machinery after taking Mitinab 400mg tablet because you may feel dizzy, drowsy or get blurred vision.
• Pregnancy: Mitinab 400mg tablet is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for 15 days after your last dose is necessary.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.


